Australia
Locksley Reports High-Grade Antimony Concentrate at Significantly Higher Grades than Comparable American Projects in Initial Metallurgical Test Work of Surface Samples from the Company's Desert Antimony Mine Project in California
SAN BERNARDINO, Calif., Oct. 8, 2025 /PRNewswire/ -- Locksley Resources, (ASX: LKY; OTCQB: LKYRF) announced that the company's advancing metallurgical test work program being conducted on surface samples collected from the Desert Antimony Mine (DAM) Prospect at the company's project in the Mojave...
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized...
FDA Lifts Clinical Hold on NUZ-001
Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...
ISX Financial EU Plc Reports Profitable Growth and Strong Capital Position in H1 2025
NICOSIA, Cyprus, Oct. 3, 2025 /PRNewswire/ -- ISX Financial EU Plc (ISXX), a leading provider of regulated transactional banking and real-time payment solutions, today announced its unaudited H1 2025 financial results for the six months ended30 June 2025. ISXX delivered profitable growth, improve...
EVOLVE MVMT Launches Wearable to Track Shock Absorption for Runners
Revolutionary running tech offers real-time insights into step quality, injury risk, and performance. BYRON BAY, Australia, Sept. 30, 2025 /PRNewswire/ -- EVOLVE MVMT has launched the world's first wearable designed specifically to measure shock absorption and step quality for runners on Kicksta...
Lumonus Announces Transformative Multi-Year Licensing Agreement with Smarter Radiation Oncology® to bring evidenced-based directives to U.S. cancer centers
NEW YORK and SYDNEY, Sept. 29, 2025 /PRNewswire/ -- Lumonus
Locksley Names Industry Veterans CEO and COO to Fast-Track its US Mine-to-Market Effort
SAN BERNARDINO, Calif., Sept. 25, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQB: LKYRF) announced the appointment ofKerrie Matthews as Chief Executive Officer (CEO) andDanny George as Chief Operating Officer (COO) of the company. The appointments are newly-created positions and...
Locksley Continues to Strengthen its Position in Paving Pathway to 100% Made in America
Company Reports Exceptional Initial Metallurgical Results for Its US Mojave Project SAN BERNARDINO, Calif, Sept. 22, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has achieved significant results from initial metallurgical testwork completed by the company on...
Aduna Welcomes Spark as First New Zealand Partner
PLANO, Texas, Sept. 17, 2025 /PRNewswire/ -- Aduna
/DISREGARD RELEASE: GIM Trading/
Journalists and other readers should disregard the news release, GIM Trading Unveils Commitment to Long-Term Investment Solutions Amid Shifts in Australian Economic Landscape, issued28-May-2024 over PR Newswire. ...
ZERO LATENCY VR INVITES YOU IN, BUT SOMETHING WON'T LET YOU LEAVE - HAUNTED IS COMING
Something horrifying is here. You are not safe. You need to get out. RUN.
MELBOURNE, Australia, Sept. 15, 2025 /PRNewswire/ -- Zero Latency VR
Locksley Resources Announces Significant Expansion of its Exploration Program for both Rare Earths and Antimony After Increasing its Landholding to More than 40 Square Kilometers in California's Mojave Region
SAN BERNARDINO, Calif., Sept. 15, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it will significantly expand its exploration program at its significantly increased landholding in the Mojave Desert. Earlier this month the company announced the addition of 249 addi...
Zeki Data Launches Company Diagnostics to Expose Hidden Risks in Deep-Tech Firms
LONDON, Sept. 11, 2025 /PRNewswire/ -- Zeki Data
Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy
SYDNEY, Sept. 11, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program led by ProfessorSudha Rao at QIMR Berghofer. In this ex vivo study, blood samples from Stage IV HER2-...
Aduna and Soprano Design, Partner to Expand Network API Adoption Across Australia and Global Markets
PLANO, Texas, Sept. 11, 2025 /PRNewswire/ -- Aduna
Aduna Signs MoU with Sekura.id, now a part of XConnect, to accelerate network API commercialization
PLANO, Texas, Sept. 10, 2025 /PRNewswire/ -- Aduna
Seeing Machines Announces Groundbreaking Impairment Detection Capability
As MADD marks its 45th anniversary, Seeing Machines unveils technology to detect alcohol impaired driving. CANBERRA, Australia, Sept. 9, 2025 /PRNewswire/ -- As hundreds of people gather inWashington, D.C. to remember loved ones killed or injured by drunk drivers, Seeing Machines announced a new...
Melitta Group becomes official coffee partner of Real Madrid
* Cooperation with one of the world's most successful soccer clubs creates visibility among the largest sports fan base worldwide * Melitta will be the exclusive coffee partner of Real Madrid for the next five years * Extensive communications and marketing package agreed for the women's and ...
$1M Forever: Halo's Enterprise Revolution Launches for Select Global Organisations
STOWMARKET, England, Sept. 8, 2025 /PRNewswire/ -- Halo, the independent leader in Enterprise Service Management (ESM), today announced"$1M Forever", a bold new enterprise package that guarantees organisations predictable, fixed ESM licensing costs for life - while delivering far faster deploymen...
Remplir™ Study Delivers Compelling 81% Success Rate
Data to support US sales roll out and EU + UK regulatory submissions * Interim results from a new Remplir™ study demonstrated a compelling overall treatment success rate of 81.1% following nerve repair procedures. * Real World Evidence (RWE) patient data collected in the study confirms Ortho...
Week's Top Stories
Most Reposted
Agoda Launches Free Global eSIMs for VIP Diamond Members
[Picked up by 322 media titles]
2026-02-10 14:00DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 320 media titles]
2026-02-16 10:00Ascentium Acquires Clara, Expanding into the Abu Dhabi Global Market (ADGM) and Strengthening its Middle East Presence
[Picked up by 310 media titles]
2026-02-12 14:00Blackpanda Japan Announces Strategic Partnership with SoftBank to Strengthen Cyber Incident Response in Japan
[Picked up by 298 media titles]
2026-02-10 13:31Carro unveils quirky generative AI ad campaign highlighting its 'Surprisingly Short' AI-enabled car-selling process
[Picked up by 296 media titles]
2026-02-11 11:00